Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 1064

1.

Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment.

Nunn AS, Fonseca EM, Bastos FI, Gruskin S, Salomon JA.

PLoS Med. 2007 Nov 13;4(11):e305.

2.

Trends and economic stress: a challenge to universal access to antiretroviral treatment in India.

Dhamija P, Bansal D, Medhi B.

Curr HIV Res. 2009 Jul;7(4):410-7.

PMID:
19601776
3.

A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.

Pinheiro Edos S, Antunes OA, Fortunak JM.

Antiviral Res. 2008 Sep;79(3):143-65. doi: 10.1016/j.antiviral.2008.05.001. Epub 2008 Jun 2. Review.

PMID:
18571246
4.

Modeling HIV/AIDS drug price determinants in Brazil: is generic competition a myth?

Meiners C, Sagaon-Teyssier L, Hasenclever L, Moatti JP.

PLoS One. 2011;6(8):e23478. doi: 10.1371/journal.pone.0023478. Epub 2011 Aug 15.

5.

Use of generic antiretroviral agents and cost savings in PEPFAR treatment programs.

Holmes CB, Coggin W, Jamieson D, Mihm H, Granich R, Savio P, Hope M, Ryan C, Moloney-Kitts M, Goosby EP, Dybul M.

JAMA. 2010 Jul 21;304(3):313-20. doi: 10.1001/jama.2010.993.

PMID:
20639565
6.

A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries.

Waning B, Diedrichsen E, Moon S.

J Int AIDS Soc. 2010 Sep 14;13:35. doi: 10.1186/1758-2652-13-35.

7.

Global strategies to reduce the price of antiretroviral medicines: evidence from transactional databases.

Waning B, Kaplan W, King AC, Lawrence DA, Leufkens HG, Fox MP.

Bull World Health Organ. 2009 Jul;87(7):520-8.

8.

The global pediatric antiretroviral market: analyses of product availability and utilization reveal challenges for development of pediatric formulations and HIV/AIDS treatment in children.

Waning B, Diedrichsen E, Jambert E, Bärnighausen T, Li Y, Pouw M, Moon S.

BMC Pediatr. 2010 Oct 17;10:74. doi: 10.1186/1471-2431-10-74.

9.

Sustaining access to antiretroviral therapy in the less-developed world: lessons from Brazil and Thailand.

Ford N, Wilson D, Costa Chaves G, Lotrowska M, Kijtiwatchakul K.

AIDS. 2007 Jul;21 Suppl 4:S21-9. Review.

PMID:
17620749
10.

Factors influencing global antiretroviral procurement prices.

Wirtz VJ, Forsythe S, Valencia-Mendoza A, Bautista-Arredondo S.

BMC Public Health. 2009 Nov 18;9 Suppl 1:S6. doi: 10.1186/1471-2458-9-S1-S6.

11.

What strategies to boost production of affordable fixed-dose anti-retroviral drug combinations for children in the developing world?

Dionisio D, Gass R, McDermott P, Racalbuto V, Madeo M, Braghieri G, Crowley S, Pinheiro Edos S, Graaff P, Vasan A, Eksaengsri A, Moller H, Khanna AK, Kraisintu K, Juneja S, Nicolaou S, Sengupta A, Esperti F, Messeri D.

Curr HIV Res. 2007 Mar;5(2):155-87.

PMID:
17346132
12.

Examining the production costs of antiretroviral drugs.

Pinheiro E, Vasan A, Kim JY, Lee E, Guimier JM, Perriens J.

AIDS. 2006 Aug 22;20(13):1745-52.

PMID:
16931939
13.
14.
15.

Allocating scarce financial resources for HIV treatment: benchmarking prices of antiretroviral medicines in Latin America.

Wirtz VJ, Santa-Ana-Tellez Y, Trout CH, Kaplan WA.

Health Policy Plan. 2012 Dec;27(8):638-48. doi: 10.1093/heapol/czs011. Epub 2012 Feb 24.

16.

Long-term costs and health impact of continued global fund support for antiretroviral therapy.

Stover J, Korenromp EL, Blakley M, Komatsu R, Viisainen K, Bollinger L, Atun R.

PLoS One. 2011;6(6):e21048. doi: 10.1371/journal.pone.0021048. Epub 2011 Jun 23.

17.

Antiretroviral drug expenditure, pricing and judicial demand: an analysis of federal procurement data in Brazil from 2004-2011.

Luo J, Oliveira MA, Ramos MB, Maia A, Osorio-de-Castro CG.

BMC Public Health. 2014 Apr 16;14:367. doi: 10.1186/1471-2458-14-367.

18.

The pricing and procurement of antiretroviral drugs: an observational study of data from the Global Fund.

Vasan A, Hoos D, Mukherjee JS, Farmer PE, Rosenfield AG, Perriëns JH.

Bull World Health Organ. 2006 May;84(5):393-8. Epub 2006 May 17.

19.

The Brazilian experiment: HIV drugs for all.

Flaer PJ, Younis MZ.

J Health Care Finance. 2009 Winter;36(2):90-6.

PMID:
20499725
20.

Retail prices of essential drugs in Brazil: an international comparison.

Nóbrega Ode T, Marques AR, de Araújo AC, Karnikowski MG, Naves Jde O, Silver LD.

Rev Panam Salud Publica. 2007 Aug;22(2):118-23.

PMID:
17976278
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk